Target
Bromodomain-containing protein 4 [49-170]
Ligand
BDBM449847
Substrate
n/a
Meas. Tech.
In Vitro Bromodomain Inhibition Assay
IC50
130±n/a nM
Citation
 Pourashraf, MJacquemot, GClaridge, SBayrakdarian, MJohnstone, SAlbert, JSGriffin, A Substituted benzimidazoles, their preparation and their use as pharmaceuticals US Patent  US11365186 Publication Date 6/21/2022 
Target
Name:
Bromodomain-containing protein 4 [49-170]
Synonyms:
BRD4 | BRD4-BD1 | BRD4-BD1 (aa 49-170) | BRD4_HUMAN | Bromodomain containing 4 (aa 49-170) | Bromodomain-containing protein 4 (BRD4) | Bromodomain-containing protein 4 (BRD4)(49-170) | Bromodomain-containing protein 4 (BRD4)(BD1) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14593.14
Organism:
Homo sapiens (Human)
Description:
aa 49-170 (BRD4-BD1)
Residue:
122
Sequence:
ETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETE
  
Inhibitor
Name:
BDBM449847
Synonyms:
5-[2-(1-acetyl-4-piperidyl)-3-[2-(trifluoromethoxy)ethyl]benzimidazol-5-yl]-1,3-dimethylpyridin-2-one | US10703740, Compound 4 | US11365186, Compound 4
Type:
Small organic molecule
Emp. Form.:
C24H27F3N4O3
Mol. Mass.:
476.4914
SMILES:
CC(=O)N1CCC(CC1)c1nc2ccc(cc2n1CCOC(F)(F)F)-c1cc(C)c(=O)n(C)c1
Structure:
Search PDB for entries with ligand similarity: